How many studies have been conducted on Busulfan?

BiohacksAI has indexed 298 PubMed studies on Busulfan, including 11 randomized controlled trials (RCTs). 55% of studies involve human subjects.

What are the main research areas for Busulfan?

The primary research domains for Busulfan are 🔬 Oncology, 🛡️ Immunity, ♀♂ Sexual Health. This is based on analysis of 298 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Busulfan

An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen.

298+ PubMed studies analyzed · 11 RCTs · Evidence Score: 47.9

Research Domains

Busulfan has been studied across 14 research domains including 🔬 Oncology, 🛡️ Immunity, ♀♂ Sexual Health, 🫁 Liver & Detox, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 17% of studies addressing this area.

Loading evidence profile...

This evidence profile for Busulfan is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.